TJBH — Tengjun Biotechnology Cashflow Statement
0.000.00%
Last trade - 00:00Consumer CyclicalsSpeculativeMicro Cap
Annual cashflow statement for Tengjun Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.048 | -0.06 | -0.054 | -0.748 | 12 |
| Depreciation | |||||
| Non-Cash Items | 0.018 | 0.02 | 0.022 | — | 0.758 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.001 | -0 | 0.001 | -0.132 | -11.7 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.03 | -0.04 | -0.032 | -0.561 | 1.35 |
| Capital Expenditures | — | — | — | -0.31 | -0.006 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | 0.29 | -0.498 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | — | — | — | -0.021 | -0.504 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.03 | 0.04 | 0.038 | 0.861 | 1.78 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | 0.006 | 0.279 | 2.55 |